Highnoon Laboratories Ltd
Mayil Qumber has extensive experience in product management, currently serving as Group Product Manager at Highnoon since October 2015, focusing on the Anti-Infective portfolio and Obstetrics & Gynecology. Prior roles at Highnoon include Senior Product Manager and Marketing Trainee Officer. Before joining Highnoon, Mayil Qumber worked as a Social Media Marketing Manager at Transparent Hands, where responsibilities included social media handling and content writing. Mayil Qumber is pursuing an Executive MBA at the Lahore School of Economics, having previously earned a Doctor of Pharmacy (PharmD) from the University of Lahore.
Highnoon Laboratories Ltd
Highnoon Laboratories Limited is a Pakistan-based pharmaceutical company. The Company is principally engaged in the manufacture, import, sale and marketing of pharmaceutical and allied consumer products. The Company offers products for various therapeutic areas, such as alimentary tract and metabolism, cardiovascular and respiratory products. The Company's product brands for alimentary tract and metabolism include Tres Orix Forte, Ulsanic, Skilax and Tagipmet. The Company's cardiovascular portfolio includes Misar brand, which is an angiotensin receptor blocker (ARB) used in the management of hypertension. Its products include AIRTAL (Aceclofenac), which has non-steroidal, anti-inflammatory and analgesic properties; ARIA (ketotifen), a non-bronchodilator antiasthamatic drug; ARTECXCIN, which acts as a blood schizotocide, and artrodar (diacerein), used for the treatment of inflammation and rheumatism. Its other products include Asthavent, AXESOME, Bezisox and Betatec.